These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 27417149)

  • 1. Pharmacokinetics of the MRI contrast agent gadobutrol in common marmoset monkeys (Callithrix jacchus).
    Helms G; Schlumbohm C; Garea-Rodriguez E; Dechent P; Fuchs E
    J Med Primatol; 2016 Dec; 45(6):290-296. PubMed ID: 27417149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and quantitative neuroimaging of the common marmoset monkey using a clinical MRI system.
    Helms G; Garea-Rodriguez E; Schlumbohm C; König J; Dechent P; Fuchs E; Wilke M
    J Neurosci Methods; 2013 Apr; 215(1):121-31. PubMed ID: 23473795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inter-individual Comparison of Gadobutrol and Gadoteridol Tissue Time-intensity Profiles for Dynamic Susceptibility Contrast Perfusion MR Imaging.
    Yamada M; Taoka T; Kawaguchi A; Yasuda K; Niinomi Y; Ohashi Y; Okuda T; Naganawa S
    Magn Reson Med Sci; 2019 Jan; 18(1):75-81. PubMed ID: 29794406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics, dose proportionality, and tolerability of gadobutrol after single intravenous injection in healthy volunteers.
    Staks T; Schuhmann-Giampieri G; Frenzel T; Weinmann HJ; Lange L; Platzek J
    Invest Radiol; 1994 Jul; 29(7):709-15. PubMed ID: 7960618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of 1M gadobutrol in patients with chronic renal failure.
    Tombach B; Bremer C; Reimer P; Schaefer RM; Ebert W; Geens V; Heindel W
    Invest Radiol; 2000 Jan; 35(1):35-40. PubMed ID: 10639034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and safety of gadobutrol-enhanced magnetic resonance imaging in pediatric patients.
    Hahn G; Sorge I; Gruhn B; Glutig K; Hirsch W; Bhargava R; Furtner J; Born M; Schröder C; Ahlström H; Kaiser S; Moritz JD; Kunze CW; Shroff M; Stokland E; Trnkova ZJ; Schultze-Mosgau M; Reif S; Bacher-Stier C; Mentzel HJ
    Invest Radiol; 2009 Dec; 44(12):776-83. PubMed ID: 19858730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P03277-A New Approach to Achieve High-Contrast Enhancement: Initial Results of an Experimental Extracellular Gadolinium-Based Magnetic Resonance Contrast Agent.
    Fries P; Müller A; Seidel R; Robert P; Denda G; Menger MD; Schneider G; Buecker A
    Invest Radiol; 2015 Dec; 50(12):835-42. PubMed ID: 26186281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and Safety of Macrocyclic Gadobutrol in Children Aged Younger Than 2 Years Including Term Newborns in Comparison to Older Populations.
    Kunze C; Mentzel HJ; Krishnamurthy R; Fleck R; Stenzel M; Bhargava R; Burrowes D; Sutter G; Schultze-Mosgau M; Santiuste M; Hahn G
    Invest Radiol; 2016 Jan; 51(1):50-7. PubMed ID: 26340504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput gadobutrol-enhanced CMR: a time and dose optimization study.
    D'Angelo T; Grigoratos C; Mazziotti S; Bratis K; Pathan F; Blandino A; Elen E; Puntmann VO; Nagel E
    J Cardiovasc Magn Reson; 2017 Nov; 19(1):83. PubMed ID: 29110679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of gadobutrol versus gadopentetate dimeglumine in enhanced MRI of brain metastases.
    Fan B; Li M; Wang X; Xu Y; Li F; Zhang L; Jiang J; Jiang Y
    J Magn Reson Imaging; 2017 Jun; 45(6):1827-1834. PubMed ID: 27696616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glymphatic MRI in idiopathic normal pressure hydrocephalus.
    Ringstad G; Vatnehol SAS; Eide PK
    Brain; 2017 Oct; 140(10):2691-2705. PubMed ID: 28969373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel gadolinium-based trimetasphere metallofullerene for application as a magnetic resonance imaging contrast agent.
    Adiseshaiah P; Dellinger A; MacFarland D; Stern S; Dobrovolskaia M; Ileva L; Patri AK; Bernardo M; Brooks DB; Zhou Z; McNeil S; Kepley C
    Invest Radiol; 2013 Nov; 48(11):745-54. PubMed ID: 23748228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraindividual comparison of gadobenate dimeglumine and gadobutrol for cerebral magnetic resonance perfusion imaging at 1.5 T.
    Essig M; Lodemann KP; Le-Huu M; Brüning R; Kirchin M; Reith W
    Invest Radiol; 2006 Mar; 41(3):256-63. PubMed ID: 16481908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using highly concentrated gadobutrol as an MR contrast agent in patients also requiring hemodialysis: safety and dialysability.
    Tombach B; Bremer C; Reimer P; Matzkies F; Schaefer RM; Ebert W; Geens V; Eisele J; Heindel W
    AJR Am J Roentgenol; 2002 Jan; 178(1):105-9. PubMed ID: 11756100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iodixanol 320 results in better renal tolerance and radiodensity than do gadolinium-based contrast media: arteriography in ischemic porcine kidneys.
    Elmståhl B; Nyman U; Leander P; Golman K; Chai CM; Grant D; Doughty R; Pehrson R; Björk J; Almén T
    Radiology; 2008 Apr; 247(1):88-97. PubMed ID: 18292474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accumulation of Gadolinium in Human Cerebrospinal Fluid after Gadobutrol-enhanced MR Imaging: A Prospective Observational Cohort Study.
    Nehra AK; McDonald RJ; Bluhm AM; Gunderson TM; Murray DL; Jannetto PJ; Kallmes DF; Eckel LJ; McDonald JS
    Radiology; 2018 Aug; 288(2):416-423. PubMed ID: 29737947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gadobutrol for magnetic resonance imaging of chronic myocardial infarction: intraindividual comparison with gadopentetate dimeglumine.
    Durmus T; Schilling R; Doeblin P; Huppertz A; Hamm B; Taupitz M; Wagner M
    Invest Radiol; 2012 Mar; 47(3):183-8. PubMed ID: 22183078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and renal tolerance of multidetector helical CT with gadobutrol: results of a comparative porcine study.
    Kalinowski M; Goldmann K; Gotthardt M; Rössler M; Pfestroff A; Klose KJ; Wagner HJ
    Radiology; 2007 Aug; 244(2):457-63. PubMed ID: 17562809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative evaluation of lesion enhancement using 1 M gadobutrol vs. 2 conventional gadolinium chelates, all at a dose of 0.1 mmol/kg, in a rat brain tumor model at 3 T.
    Attenberger UI; Runge VM; Jackson CB; Baumann S; Birkemeier K; Michaely HJ; Schoenberg SO; Reiser MF; Wintersperger BJ
    Invest Radiol; 2009 May; 44(5):251-6. PubMed ID: 19550376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraindividual quantitative and qualitative comparison of gadopentetate dimeglumine and gadobutrol in time-resolved contrast-enhanced 4-dimensional magnetic resonance angiography in minipigs.
    Hadizadeh DR; Jost G; Pietsch H; Weibrecht M; Perkuhn M; Boschewitz JM; Keil VC; Träber F; Kukuk GM; Schild HH; Willinek WA
    Invest Radiol; 2014 Jul; 49(7):457-64. PubMed ID: 24598442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.